Abeona Therapeutics Inc. Stock
Abeona Therapeutics Inc. Stock
There is an upward development for Abeona Therapeutics Inc. compared to yesterday, with an increase of €0.10 (2.510%).
With 10 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 17 € there is potential for a 316.67% increase which would mean more than doubling the current price of 4.08 € for Abeona Therapeutics Inc..
Our community identified positive and negative aspects for Abeona Therapeutics Inc. stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Abeona Therapeutics Inc. stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Abeona Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Abeona Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc. | 2.510% | -5.556% | 7.937% | -27.143% | -22.286% | 9.677% | -86.628% |
| Ardelyx Inc. | -0.470% | 1.501% | -0.696% | -1.154% | 3.525% | 187.536% | -1.306% |
| Krystal Biotech | 5.350% | 6.399% | 15.665% | 18.562% | 32.194% | 164.737% | - |
| Evolus Inc | 0.890% | -5.042% | -1.739% | -52.521% | -46.190% | -16.296% | 86.346% |
Comments
Abeona Therapeutics (NASDAQ:ABEO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc. (NASDAQ: ABEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc. (NASDAQ: ABEO) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $19.00 to $20.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ABEO provided by MarketBeat